WARFARIN HAS NO NEGATIVE IMPACT ON FIBRINOLYSIS

被引：3

作者：

SMITH, P ^{[1
]}

ARNESEN, H ^{[1
]}

OPSTAD, T ^{[1
]}

KIERULF, P ^{[1
]}

机构：

[1] ULLEVAL HOSP,CENT LAB,OSLO 1,NORWAY

来源：

THROMBOSIS RESEARCH | 1990年 / 58卷 / 06期

关键词：

fibrinolytic capacity; lipids; Warfarin;

D O I：

10.1016/0049-3848(90)90311-Y

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：653 / 656

页数：4

共 10 条

[1]

ANDERSEN P, 1981, ACTA MED SCAND, V209, P199

[2]

ANDERSEN P, IN PRESS THROMBOS HA

[3] CHANGES IN FIBRINOLYTIC CAPACITY AND LIPOPROTEIN PATTERN DURING LONG-TERM TREATMENT WITH WARFARIN [J].

ARNESEN, H ;

SMITH, P ;

ASPELUND, EB .

THROMBOSIS RESEARCH, 1986, 44 (02) :229-233

[4] EVIDENCE FOR A RAPID INHIBITOR TO TISSUE PLASMINOGEN-ACTIVATOR IN PLASMA [J].

CHMIELEWSKA, J ;

RANBY, M ;

WIMAN, B .

THROMBOSIS RESEARCH, 1983, 31 (03) :427-436

[5]

LOELIGER EA, 1985, THROMB HAEMOSTASIS, V54, P515

[6]

NORDBY E, 1980, SCAND J HAEMATOL, V25, P407

[7]

ROBERTSON BR, 1972, ACTA CHIR SCAND, V138, P429

[8]

SMITH P, UNPUB N ENGL J MED

[9]

WALLACE RB, 1980, CIRCULATION, V62, P77

[10] PLASMINOGEN-ACTIVATOR RELEASE DURING VENOUS STASIS AND EXERCISE AS DETERMINED BY A NEW SPECIFIC ASSAY [J].

WIMAN, B ;

MELLBRING, G ;

RANBY, M .

CLINICA CHIMICA ACTA, 1983, 127 (02) :279-288

← 1 →